Pathogenetic therapy with ivacaftor + tezacaftor + elexacaftor plus ivacaftor: Assessment of efficacy and safety of switching within a single INN in children with cystic fibrosis in the Yaroslavl and Tula regions

Meditsinskiy Sovet · Published 2026-07-24 · DOI 10.21518/ms2026-283

Free full text

Authors (9)

E. V. Fateeva, L. V. Smirnova, V. V. Tarakanova, T. A. Basayeva, D. V. Kharitonov, N. M. Gaponova, Yu. Yu. Terekhova, E. V. Mamchenkova, V. A. Slavskaya

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Fateeva, E., Smirnova, L., Tarakanova, V., et al. (2026). Pathogenetic therapy with ivacaftor + tezacaftor + elexacaftor plus ivacaftor: Assessment of efficacy and safety of switching within a single INN in children with cystic fibrosis in the Yaroslavl and Tula regions. Meditsinskiy Sovet. https://doi.org/10.21518/ms2026-283

Related articles